CCTST "T1 Awardees Announced

The CCTST’s Pilot & Collaborative Studies (PCS) core has announced $1.3 million in FY2013 awards to facilitate T1 research.

T1 (Translation 1) research seeks to apply clinical or basic research knowledge in an identifiable pathway toward the development of trials and studies in humans.

Included were 11 full T1 awards of up to $100,000, four junior T1 awards of up to $25,000 and two innovative core service awards of up to $50,000. Four of the T1 awards and two of the Junior T1 awards included UC-CCHMC cross-institutional/interdisciplinary collaborations.

This was the fourth annual funding round of T1 grants, which expanded the highly successful Translational Research Initiative (TRI) at CCHMC to investigators across the AHC and UC west campus.

Congratulations to the awardees!

T1 principal investigators
  • Raouf Amin, MD, pulmonary medicine, CCHMC
  • Hermine Brunner, MD, MSc, rheumatology, CCHMC
  • Pankaj Desai, PhD, pharmacy, UC
  • Sonata Jodele, MD, bone marrow transplantation & immune deficiency, CCHMC
  • Michael Jordan, MD, immunobiology, CCHMC
  • Robert McNamara, PhD, psychiatry, UC
  • Marshall Montrose, PhD, molecular & cellular physiology, UC
  • James Mulloy, PhD, experimental hematology & cancer biology, CCHMC
  • Charles Quinn, MD, MS, hematology, CCHMC
  • Kimberly Risma, MD, PhD, allergy & immunology, CCHMC (2nd year)
  • Takuji Suzuki, PhD, pulmonary biology, CCHMC
Junior T1 principal investigators
  • Aimee Dietz, PhD, allied health sciences, UC
  • Yu Li, PhD, radiology, CCHMC
  • Karen Ryan, PhD, endocrinology, diabetes & metabolism, UC
  • Yuhang Zhang, pharmacy and dermatology, UC
Innovative core directors
  • Prasad Devarajan, MD, nephrology, CCHMC
  • Charles Dumoulin, PhD, radiology, CCHMC
A table of awards including project titles and co-investigators is available here.

Tags

Related Stories

2

Funding expands UC research into weight gain side effects of bipolar medication

August 26, 2026

University of Cincinnati researchers have been approved for funding by the Patient-Centered Outcomes Research Institute (PCORI) to expand the implementation of healthy lifestyle interventions and metformin prescription to help manage weight gain in overweight or obese youth taking second-generation antipsychotic medications.

3

One in four NFL players had CTE at death

August 25, 2026

Forbes cites research on concussions and football helmets by the University of Cincinnati in a report that found one in four NFL players had brain damage at death.